Imagine an APP for nuclei segmentation that is reliable and can be used by anyone in your lab.
Recent advances in deep learning and artificial intelligence have enabled Visiopharm to develop novel tools for nuclei segmentation in brightfield images, providing you with the accuracy, precision and ease-of-use you have been waiting for.
Whether you are an image analysis expert or a novice user, you can expect results quickly.
This presentation will highlight Visiopharm’s new AI Nuclei APP and how it can be combined with other AI and machine learning APPs to generate accurate and meaningful results.
This webinar was presented live on Tuesday, December 10th, 2019.
Ben Freiberg has a PhD in Immunology from the University of Colorado and has been imaging in one form or another since 1995. He has been at Visiopharm for 5 years focused on solving the digital pathology needs of our global customer base. He has recently been appointed VP of Research Product where he oversees product management of Visiopharm’s image analysis platforms for research.